Start Date
Immediate
Expiry Date
17 Dec, 26
Salary
75000.0
Posted On
18 Sep, 26
Experience
15 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Industry
Healthcare & Life Sciences
Vertanical – A World Free of Chronic Pain. We are a leading global biopharmaceutical company specializing in the development and distribution of innovative medicines for the treatment of chronic pain. Our vision is clear: a world free of chronic pain! With VER-01, we have developed a unique cannabinoid-based medicine for the treatment of chronic pain, which was approved in Germany and Austria in June 2026 under the name Exilby. This marks a significant milestone after more than eight years of intensive research and development.
Approval in the USA is planned for 2029. Our goal is to establish Exilby as the leading therapy for the treatment of chronic pain by 2030, setting new standards in pain management. Does
this sound exciting to you? Then apply now! We look forward to getting to know you.
Are you interested in helping shape clinical trials from start to finish and mastering technical and organizational challenges? Then join our team and help us shape the future of pain therapy!
At Vertanical, you can expect not only exciting clinical trial projects but also the opportunity to apply your expertise in data management and analysis at the highest level. Here, you will actively contribute to the future of innovative cannabinoid-based medicines and work closely with a highly motivated team. You are not only detail-oriented but also strategic, enabling you to transform data into groundbreaking insights. If you are eager to help design processes from the ground up and take on responsibility, then this is the perfect place for you!
How To Apply:
Incase you would like to apply to this job directly from the source, please click here
Vertanical – A World Free of Chronic Pain. We are a leading global biopharmaceutical company specializing in the development and distribution of innovative medicines for the treatment of chronic pain. Our vision is clear: a world free of chronic pain! With VER-01, we have developed a unique cannabinoid-based medicine for the treatment of chronic pain, which was approved in Germany and Austria in June 2026 under the name Exilby. This marks a significant milestone after more than eight years of intensive research and development.
Approval in the USA is planned for 2029. Our goal is to establish Exilby as the leading therapy for the treatment of chronic pain by 2030, setting new standards in pain management. Does
this sound exciting to you? Then apply now! We look forward to getting to know you.
Are you interested in helping shape clinical trials from start to finish and mastering technical and organizational challenges? Then join our team and help us shape the future of pain therapy!
At Vertanical, you can expect not only exciting clinical trial projects but also the opportunity to apply your expertise in data management and analysis at the highest level. Here, you will actively contribute to the future of innovative cannabinoid-based medicines and work closely with a highly motivated team. You are not only detail-oriented but also strategic, enabling you to transform data into groundbreaking insights. If you are eager to help design processes from the ground up and take on responsibility, then this is the perfect place for you!